Genetic polymorphism of CYP2C8 in three Malaysian ethnics:: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians

被引:25
作者
Muthiah, YD
Lee, WL
Teh, LK
Ong, CE
Ismail, R [1 ]
机构
[1] Univ Sains Malaysia, Inst Res Mol Med, Pharmacogenet Study Grp, Kelantan 16150, Malaysia
[2] Univ Sains Malaysia, Sch Med Sci, Dept Pharmacol, Kelantan 16150, Malaysia
[3] Univ Teknol Mara, Fac Pharm, Selangor, Malaysia
[4] Int Med Univ, Dept Pharm, Kuala Lumpur, Malaysia
关键词
allele frequency; CYP2C8; polymorphism;
D O I
10.1111/j.1365-2710.2005.00653.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: CYP2C8 is genetically polymorphic. Four variants, CYP2C8*2, CYP2C8*3, CYP2C8*4 and CYP2C8*5, which contain mutations in the coding regions have been reported to exhibit different enzyme activity as compared with CYP2C8*1. Objective: To determine the allele frequency of three codon-changing variants (CYP2C8*2, CYP2C8*3 and CYP2C8*4) in the Malaysian population. Method: Healthy unrelated volunteers from three major races in Malaysia were recruited. The study was approved by the local Research Ethics Committee. DNA was extracted using a standard protocol. A two-step multiplex PCR method was developed to detect three alleles of CYP2C8. PCR results were confirmed by subsequent direct DNA sequencing. Result: Only the Indians showed CYP2C8 polymorphism with allele frequency of 98% for CYP2C8*1, 0.8% for CYP2C8*2 and 1.2% for CYP2C8*3. CYP2C8*4 was not detected in any of the ethnic groups. Conclusion: To the best of our knowledge, the current study described, for the first time polymorphisms of CYP2C8 in Malaysian Indians.
引用
收藏
页码:487 / 490
页数:4
相关论文
共 10 条
[1]   CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes [J].
Bahadur, N ;
Leathart, JBS ;
Mutch, E ;
Steimel-Crespi, D ;
Dunn, SA ;
Gilissen, R ;
Van Houdt, J ;
Hendrickx, J ;
Mannens, G ;
Bohets, H ;
Williams, FM ;
Armstrong, M ;
Crespi, CL ;
Daly, AK .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (11) :1579-1589
[2]  
Baldwin SJ, 1999, BRIT J CLIN PHARMACO, V48, P424
[3]   Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid [J].
Dai, D ;
Zeldin, DC ;
Blaisdell, JA ;
Chanas, B ;
Coulter, SJ ;
Ghanayem, BI ;
Goldstein, JA .
PHARMACOGENETICS, 2001, 11 (07) :597-607
[4]  
ISMAIL R, 2003, J CLIN PHARM THERAPE, V28, P1
[5]  
Klose TS, 1999, J BIOCHEM MOL TOXIC, V13, P289, DOI 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO
[6]  
2-N
[7]   Genetic polymorphisms of CYP2C8 in Japanese population [J].
Nakajima, M ;
Fujiki, Y ;
Noda, K ;
Ohtsuka, H ;
Ohkuni, H ;
Kyo, S ;
Inoue, M ;
Kuroiwa, Y ;
Yokoi, T .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) :687-690
[8]  
RAHMAN A, 1994, CANCER RES, V54, P5543
[9]  
Soyama Akiko, 2002, Drug Metab Pharmacokinet, V17, P374, DOI 10.2133/dmpk.17.374
[10]  
YUN CH, 1992, CANCER RES, V52, P1868